- call +1-201-465-4211
- email sales@mrinsights.biz
Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy.
Scope of the Report:
The global Left Ventricular Assist Device Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Left Ventricular Assist Device Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Left Ventricular Assist Device Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Left Ventricular Assist Device Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
Abiomed
Berlin Heart
Thoratec
Jarvik Heart
HeartWare
Apaxis
CorWave
Evaheart
St Jude Medical
Reliantheart
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Destination therapy
Bridge to transplantation
Bridge to recovery
Bridge to destination
Market Segment by Applications, can be divided into
Hospitals
Cardiology Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Left Ventricular Assist Device Treatment Market Overview
1.1 Product Overview and Scope of Left Ventricular Assist Device Treatment
1.2 Classification of Left Ventricular Assist Device Treatment by Types
1.2.1 Global Left Ventricular Assist Device Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Left Ventricular Assist Device Treatment Revenue Market Share by Types in 2017
1.2.3 Destination therapy
1.2.4 Bridge to transplantation
1.2.5 Bridge to recovery
1.2.6 Bridge to destination
1.3 Global Left Ventricular Assist Device Treatment Market by Application
1.3.1 Global Left Ventricular Assist Device Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Cardiology Centers
1.4 Global Left Ventricular Assist Device Treatment Market by Regions
1.4.1 Global Left Ventricular Assist Device Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Left Ventricular Assist Device Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Left Ventricular Assist Device Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Left Ventricular Assist Device Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Left Ventricular Assist Device Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Left Ventricular Assist Device Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Left Ventricular Assist Device Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Left Ventricular Assist Device Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abiomed
2.2.1 Business Overview
2.2.2 Left Ventricular Assist Device Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abiomed Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Berlin Heart
2.3.1 Business Overview
2.3.2 Left Ventricular Assist Device Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Berlin Heart Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thoratec
2.4.1 Business Overview
2.4.2 Left Ventricular Assist Device Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thoratec Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jarvik Heart
2.5.1 Business Overview
2.5.2 Left Ventricular Assist Device Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jarvik Heart Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 HeartWare
2.6.1 Business Overview
2.6.2 Left Ventricular Assist Device Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HeartWare Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Apaxis
2.7.1 Business Overview
2.7.2 Left Ventricular Assist Device Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Apaxis Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 CorWave
2.8.1 Business Overview
2.8.2 Left Ventricular Assist Device Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CorWave Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Evaheart
2.9.1 Business Overview
2.9.2 Left Ventricular Assist Device Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Evaheart Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 St Jude Medical
2.10.1 Business Overview
2.10.2 Left Ventricular Assist Device Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 St Jude Medical Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Reliantheart
2.11.1 Business Overview
2.11.2 Left Ventricular Assist Device Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Reliantheart Left Ventricular Assist Device Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Left Ventricular Assist Device Treatment Market Competition, by Players
3.1 Global Left Ventricular Assist Device Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Left Ventricular Assist Device Treatment Players Market Share
3.2.2 Top 10 Left Ventricular Assist Device Treatment Players Market Share
3.3 Market Competition Trend
4 Global Left Ventricular Assist Device Treatment Market Size by Regions
4.1 Global Left Ventricular Assist Device Treatment Revenue and Market Share by Regions
4.2 North America Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
5 North America Left Ventricular Assist Device Treatment Revenue by Countries
5.1 North America Left Ventricular Assist Device Treatment Revenue by Countries (2013-2018)
5.2 USA Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
6 Europe Left Ventricular Assist Device Treatment Revenue by Countries
6.1 Europe Left Ventricular Assist Device Treatment Revenue by Countries (2013-2018)
6.2 Germany Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
6.4 France Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Left Ventricular Assist Device Treatment Revenue by Countries
7.1 Asia-Pacific Left Ventricular Assist Device Treatment Revenue by Countries (2013-2018)
7.2 China Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
7.5 India Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
8 South America Left Ventricular Assist Device Treatment Revenue by Countries
8.1 South America Left Ventricular Assist Device Treatment Revenue by Countries (2013-2018)
8.2 Brazil Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Left Ventricular Assist Device Treatment by Countries
9.1 Middle East and Africa Left Ventricular Assist Device Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Left Ventricular Assist Device Treatment Revenue and Growth Rate (2013-2018)
10 Global Left Ventricular Assist Device Treatment Market Segment by Type
10.1 Global Left Ventricular Assist Device Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Left Ventricular Assist Device Treatment Market Forecast by Type (2018-2023)
10.3 Destination therapy Revenue Growth Rate (2013-2023)
10.4 Bridge to transplantation Revenue Growth Rate (2013-2023)
10.5 Bridge to recovery Revenue Growth Rate (2013-2023)
10.6 Bridge to destination Revenue Growth Rate (2013-2023)
11 Global Left Ventricular Assist Device Treatment Market Segment by Application
11.1 Global Left Ventricular Assist Device Treatment Revenue Market Share by Application (2013-2018)
11.2 Left Ventricular Assist Device Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Cardiology Centers Revenue Growth (2013-2018)
12 Global Left Ventricular Assist Device Treatment Market Size Forecast (2018-2023)
12.1 Global Left Ventricular Assist Device Treatment Market Size Forecast (2018-2023)
12.2 Global Left Ventricular Assist Device Treatment Market Forecast by Regions (2018-2023)
12.3 North America Left Ventricular Assist Device Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Left Ventricular Assist Device Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Left Ventricular Assist Device Treatment Revenue Market Forecast (2018-2023)
12.6 South America Left Ventricular Assist Device Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Left Ventricular Assist Device Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Left Ventricular Assist Device Treatment Picture
Table Product Specifications of Left Ventricular Assist Device Treatment
Table Global Left Ventricular Assist Device
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
